Gene-diet interaction in determining plasma lipid response to dietary intervention

Atherosclerosis

Volumn 118, Issue SUPPL., 1995, Pages

  Ordovas, Jose M ^a   Lopez Miranda, Jose ^a   Mata, Pedro ^a   Perez Jimenez, Francisco ^a   Lichtenstein, Alice H ^a   Schaefer, Ernst J ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Apolipoproteins; Diet; Genetics; Lipoproteins

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CONFERENCE PAPER; CORONARY ARTERY DISEASE; DIET; GENE MUTATION; GENETICS; HUMAN; HYPERCHOLESTEROLEMIA; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0029583185     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(95)90069-1     Document Type: Article

References (188)

1. Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors
2. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel 11)
3. The influence of dietary fats on serum lipid levels in man
4. ‘Essential’ fatty acids degree of unsaturation, and effect of corn oil on the serum cholesterol level in man
5. Nutritional factors and serum lipid levels
6. Prediction of serum cholesterol responses of man to changes in fats in the diet
7. Serum cholesterol response to changes in the diet. IV. Particular saturated fatty acids in the diet
8. Quantitative effects of dietary fat on serum cholesterol in man
9. Dietary fat and serum lipids: An evaluation of the experimental data
10. Effect of dietary fatty acids on serum lipids and lipoproteins: A meta-analysis of 27 trials
11. Determinants of plasma cholesterol responsiveness to diet
12. Diet and blood cholesterol in normal women
13. Existence of consistent hypo- and hyperresponders to dietary cholesterol in man
14. Variability in individual serum cholesterol response to change in diet
15. Low density lipoprotein cholesterol responsiveness to diet in normolipidemic subjects
16. Relationship between sensitivity to dietary fat and dietary cholesterol
17. Cholesterol metabolism in groups of rhesus monkeys with high or low response of serum cholesterol to an atherogenic diet
18. Cholesterol metabolism in two strains of rabbits differing in their cholesterolaemic response to dietary cholesterol
19. Genetic studies on induced and spontaneous hypercholesterolemia in rats
20. Individual differences in the response of serum cholesterol to change in diet: Animal studies
21. A protein co-factor of lecithin: cholesterol acyltransferase
22. Pathophysiology of reverse cholesterol transport: Insights from inherited disorders of liporptein metabolism
23. Apolipoprotein multigene family: Tandem organization of human apolipoprotein A-l, CIII and A-IV genes
24. Human apolipoprotein A-I/C-111 gene complex is located in chromosome 11
25. Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III A-IV gene locus. Relationships with lipids, apolipoproteins, and premature coronary artery disease
26. Genetic markers in the apo AI-CIII-AIV gene cluster for combined hyperlipidemia, hypertriglyceridemia, and predisposition to atherosclerosis
27. Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: Detection of genetic variation determining plasma apo A-1, apo C-111 and apo A-IV concentrations
28. Apolipoprotein polymorphisms fail to define risk of coronary artery disease: Results of a prospective, angiographically controlled study
29. Familial polipoprotein A-I and C-III deficiency, variant 11
30. Familial apolipoprotein A-I, C-111 and A-IV deficiency and premature atherosclerosis due to deletion of a gene complex on chromosome 11
31. DNA inversion within the apolipoproteins AI/CIII/AIV-encoding gene cluster of certain patients with premature atherosclerosis
32. Genetic variation at the apolipoprotein A-1,C-111,A-IV gene complex
33. Genetic HDL deficiency states
34. Characterization of atherosclerosis in a patient with familial high density lipoprotein deficiency
35. A nonsense mutation in the apolipoprotein A-I gene is associated with high density lipoprotein deficiency and periorbital xanthelasmas
36. A frameshift mutation in the human apolipoprotein A-1 gene causes high density lipo protein deficiency, partial lecithin:cholesterol-acyltransferase deficiency, and corneal opacities
37. High density lipoproteins, reverse transport of cholesterol, and coronary artery disease: Insights from mutations
38. G to A substitution in the promoter region of the apolipoprotein A-I gene is associated with elevated serum apolipo protein A-I and high density lipoprotein cholesterol concentrations
39. Human apolipoprotein A-I gene promoter polymorphism: Association with hyperalphalipoproteinemia
40. Interaction between a polymorphism of the apo A-I promoter region and smoking determines plasma levels of HDL and apo A-I
41. Guanidine to adenine (G/A) substitution in the promoter region of the apolipoprotein A-I gene is associated with elevated serum apolipoprotein A-I levels in Chinese non-smokers
42. Role of genetic variation at the apo AI-CIII-AIV gene cluster in determining plasma apo A-I levels in boys and girls
43. Genetic analysis of a polymorphism in the human apolipoprotein A-1 gene promoter: Effect on plasma HDL-cholesterol levels
44. Adenine for guanine substitution - 78 base pairs to the apolipoprotein (apo) A-I gene: relation with high density lipoprotein cholesterol and apo A-I concentrations
45. Polymorphism in the human apolipoprotein A-I gene promoter region. Association of the minor allele with decreased produc tion rate in vivo and promoter activity in vitro
46. Transcription efficiency of human apolipoprotein A-I promoter varies with naturally occurring A to G transition
47. A polymorphism (G → A transition) in the - 78 position of the apolipoprotein A-I promoter increases transcription efficiency
48. Genetic analysis of apolipoprotein A-1 in two dietary environments
49. Genetic variation at the apolipoprotein gene loci contributes to response of plasma lipids to dietary change
50. Influence of mutation in human apolipoprotein A-I gene promoter on plasma LDL cholesterol response to dietary fat
51. Human apolipoprotein A-IV. Intestinal origin and distribution in plasma
52. Studies on the in vivo and in vitro distribution of apolipoprotein A-IV in human plasma and lymph
53. Distribution of apolipoprotein A-IV in human plasma
54. Evidence for high density lipoproteins as the major apolipoprotein A-IV-containing fraction in normal human serum
55. Lipoprotein apo C-11 activation of lipoprotein lipase. Modulation by apolipoprotein A-IV
56. Activation of lecithin:cholesterol acyltransferase by human apolipoprotein A-IV
57. The role of apolipoprotein A-IV in reverse cholesterol transport studied with cultured cells and liposomes derived from an ether analog of phosphatidylcholine
58. Human apolipoprotein A-IV binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells
59. Binding of human apolipoprotein A-IV to human hepatocellular plasma membranes
60. Genetic polymorphism of six plasma proteins in the domestic cat
61. Highly polymorphic apolipoprotein A-IV locus in the baboon
62. A previously reported polymorphic plasma protein of dogs and horses identified as apolipoprotein A-IV
63. Lipoprotein profile of a Greenland Inuit population. Influence of anthropometric variables, apo E and A4 polymorphism, and lifestyle
64. Genetic studies of human apolipoproteins. XVII: Population genetics of apolipoprotein polymorphisms in American Samoa
65. Molecular basis of a unique African variant (A-IV 5) of human apolipoprotein A-IV and its significance in lipid metabolism
66. Apolipoprotein A-IV genetic polymorphism and its impact on quantitative traits in normoglycemic and non-insulin-dependent diabetic Hispanics from the San Luis Valley, Colorado
67. Apolipoprotein A-IV polymorphism in Singapore ethnic groups
68. Human plasma apolipoproteins A-IV-0 and A-IV-3. Molecular basis for two rare variants of apolipoprotein A-IV-I
69. Genetic polymorphism of human plasma apolipoprotein A-IV gene
70. 165 → Lys)
71. Genetic studies of human apolipoproteins. VII. Population distribution of poly morphisms of apolipoproteins A-I A-II, A-IV, C-II, E, and H in Nigeria
72. Frequency and effect of human apolipoprotein A-IV polymorphism on lipid and lipoprotein levels in an Icelandic population
73. Population study of apolipoprotein A-IV polymorphism and report of a new variant in Japanese
74. Polymorphic site study at codon 347 of apolipoprotein A-IV in a Japanese population
75. Nonsynonymous polymorphic sites in the apolipoprotein (apo) A-IV gene are associ ated with changes in the concentration of apo B- and apo A-1-containing lipoproteins in a normal population
76. A novel polymorphism of apolipoprotein A-IV is the result of an asparagine to serine substitution at residue 127
77. Effects of polymorphisms in apolipoproteins E, A-IV, and H on quantitative traits related to risk for cardiovascular disease
78. Apolipoprotein A-IV polymorphism, and its role in determining variation in lipoprotein-lipid, glucose and insulin levels in normal and non-insulin-dependent diabetic individuals
79. Phenotypic effects of apolipoprotein structural variation on lipid profiles: 11. Apolipoprotein A-IV and quantitative lipid measures in the healthy women study
80. Human apolipoprotein A-IV polymorphism: Frequency and effect on lipid and lipoprotein levels
81. Apolipoprotein A-IV polymorphism and its effect on plasma lipid and apolipoprotein concentrations
82. Population genetics of apolipoprotein A-4, E, and H polymorphisms in Yanomami Indians of northwestern Brazil: associations with lipids, lipoproteins, and carbohydrate metabolism
83. Apolipoprotein A-IV protein polymorphism: Frequency and effects on lipids lipoproteins, and apolipoproteins among Mexican-Americans in Starr County, Texas
84. DNA polymorphisms of human apolipoprotein A-IV gene: Frequency and effects on lipid, lipo protein and apolipoprotein levels in a French population
85. Apo A-IV phenotype affects diet-induced plasma LDL cholesterol lowering
86. Attenuated hypercholesterolemic response to a highcholesterol diet in subjects heterozygous for the apolipoprotein A-IV-2 allele
87. Apolipoprotein E isoform phenotype and LDL subclass response to a reduced-fat diet
88. Rapid in vivo transport and catabolism of human apolipoprotein AIV-1 and slower catabolism of the Apo A-IV-2 isoprotein
89. Complete protein sequence and identification of structural domains of human apolipoprotein B
90. Sequence structure, receptor binding domains and internal repeats of human apolipoprotein B-100
91. Human liver apolipoprotein B-100 cDNA: complete nucleic acid and derived amino acid sequence
92. The complete sequence and structural analysis of human apolipoprotein B-100: Re lationship between apo B-100 and apo B-48 forms
93. Both apolipoproteins B-48 and B-100 are synthesized and secreted by the human intestine
94. Apolipoprotein B-100: Immunolocalization and synthesis in human intestinal mucosa
95. Effect of fat feeding on human intestinal apolipoprotein B mRNA levels and editing
96. Characterization of the apolipoprotein B mRNA editing activity in enterocyte extracts
97. Apolipoprotein B mRNA editing is an intranuclear event that occurs post-transcriptionally coincident with splicing and polyadenylation
98. Structure of the human apolipoprotein B gene
99. Human apolipoprotein B-100: Cloning, analysis of liver mRNA, and assignment of the gene to chromosome 2
100. Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels
101. DNA polymorphism at the apolipoprotein B locus is associated with lipoprotein level
102. Association of DNA polymorphism at the apolipoprotein B gene locus with coronary heart disease and serum very low density lipoprotein levels
103. Apolipoprotein B gene polymorphisms lipoproteins and coronary atherosclerosis: A study of young myocardial infarction survivors and healthy population-based individuals
104. Apolipoprotein B gene polymorphisms in ischemic heart disease and hyperc holesterolemia: effects of age and sex
105. Variability gene effects of DNA polymorphisms at the apo B, apo A-I/CIII and apo E loci on serum lipids: The Cardiovas cular Risk in Young Finns Study
106. Associations of genotypes at the apoliprotein AI-CIII-AIV apolipoprotein B and lipo protein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses
107. Apolipoprotein B gene DNA polymorphisms associated with myocardial infarction
108. DNA polymorphism of the gene for apolipoprotein B in patients with peripheral arterial disease
109. Restriction fragment length polymorphism in the apo B gene in relation to coronary artery disease
110. The Xbal polymorphism at the apolipoprotein B locus and risk of atherosclerotic disease
111. XbaI polymorphism of the apolipoprotein B gene influences plasma lipid response to diet intervention
112. Dietary intake and gene variation influence the response of plasma lipids to dietary intervention
113. Apolipoprotein B signal peptide insertion/deletion polymorphism is associated with Ag epitopes and involved in the determination of serum triglyceride levels
114. A three codon insertion/deletion polymorphism in the signal peptide region of the human apolipoprotein B gene directly typed by the polymerase chain reaction
115. Apolipoprotein B gene polymorphisms are associated with lipid levels in men of South Asian descent
116. Apolipoprotein B signal peptide polymorphism in patients with myocardial infarction and controls. ‘The ECTIM study’
117. Influence of apolipoprotein B signal peptide insertion/deletion polymorphism on serum lipids and apolipoproteins in a Chinese population
118. Apo B insertion/deletion polymorphisms are associated with atherosclerosis in young black but not young white males
119. The apolipoprotein B signal peptide insertion/deletion polymorphism is not associated with myocardial infarction in Norway
120. Role of apolipoprotein E and B gene variation in determining response of lipid, lipoprotein, and apolipoprotein levels to increased dietary cholesterol
121. Apo B gene RFLP in exon 26 changes amino acid 3611 from Arg to Gln
122. DNA polymorphisms of the apolipoprotein B gene in patients with premature coronary artery disease
123. A unique AT-rich hypervariable minisatellite 3′ to the apo B gene defines a high information restriction fragment length polymorphism
124. Strategies for multilocus linkage analysis in humans
125. Hypervariability in a minisatellite 3′ of the apolipoprotein B gene in patients with coronary heart disease compared with normal controls
126. Apolipoprotein B gene 3′ hypervariable region polymorphism and myocardial infarction in dyslipidemic Finnish men participating in a primary prevention trial
127. Distribution of apolipoprotein A-I, C-II C-III, and E mRNA in fetal human tissues. Time dependent induction of apolipoprotein E mRNA by cultures of human monocyte-macrophages
128. Modulation of lipoprotein lipase activity by lipoproteins. Effect of apolipoprotein C-III
129. Apolipoprotein C-I modulates the interaction of apolipoprotein E with beta-migrating very low density lipoproteins and inhibits binding of beta-VLDL to low density lipoprotein receptor-related protein
130. Opposing effects of apolipoprotein E and C on lipoprotein binding to low density lipoprotein receptor related protein
131. Hypertriglyceridemia as a result of human apo CHI gene expression in transgenic mice
132. Apolipoprotein C-III(Lys58Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia
133. Genetic polymorphisms of apolipoprotein C-l1I and insulin in survivors of myocardial infarction
134. Restriction fragment length polymorphisms of the apolipoprotein A-1, C-111 A-IV gene locus: Relationships with lipids, apolipoproteins, and premature coronary artery disease
135. An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms
136. Regulation of apolipoprotein CIII gene transcription by insulin: characterization of an insulin response element in the CIII promoter
137. A common variant of the apo CIII promoter associated with hypertriglyceridemia is defective in its transcriptional response to insulin
138. TheSstI polymorphic site at the apolipoprotein C-111 gene predicts plasma low density lipoprotein response to changes in dietary fat in young men
139. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein
140. Apolipoprotein E:cholesterol transport protein with expanding role in cell biology
141. Familial apolipoprotein E deficiency
142. Apolipoprotein E polymorphism and atherosclerosis
143. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation
144. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations
145. The use of measured genotype information in the analysis of quantitative phenotypes in man
146. Impact of apolipoprotein E polymorphism in determining interindividual variation in total cholesterol and low density lipoprotein cholesterol in Hispanics and nonHispanic whites
147. Influences of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health
148. Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apo El and apo E5 isoforms
149. Apolipoprotein E phenotype affects plasma lipoprotein levels in a gender- and menopausal status-dependent manner
150. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man
151. Magnitude of dietary effects on plasma cholesterol concentration: Role of sex and apolipoprotein E phenotype
152. Independent effects of dietary saturated fat and cholesterol on plasma lipids, lipoproteins, and apolipoprotein E
153. Apolipoprotein E4 homozygosity predisposes to serum cholesterol elevation during high fat diet
154. Apolipoprotein E polymorphism influences the serum cholesterol response to dietary intervention
155. Influence of dietary fat, apolipoprotein E phenotype, and sex on plasma lipoprotein levels
156. Cholesterol absorption, elimination, and synthesis related to LDL kinetics during varying fat intake in men with different apoprotein E phenotypes
157. Serum cholesterol response to dietary cholesterol and apoprotein E phenotype
158. Cholesterol-rich diet induced changes in plasma lipids in relation to apolipoprotein E phenotype in healthy students
159. Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol
160. Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: Relationship to apolipoprotein E genotype
161. Plasma lipids and lipoproteins in response to a dietary challenge: analysis of four candidate genes
162. Longterm effects of three fat-modified diets in hypercholesterolemic subjects
163. Effect of apolipoprotein E polymorphism on the serum lipid response to a hypolipidemic diet rich in monounsaturated fatty acids in patients with hypercholesterolemia and combined hyperlipidemia
164. Response of serum cholesterol to dietary cholesterol in relation to apolipoprotein E phenotype
165. A dose-response study of the effects of dietary cholesterol on fasting and postprandial lipid and lipoprotein metabolism in healthy young men
166. Effect of apolipoprotein E and A-IV phenotypes on the low density lipoprotein response to HMG-CoA reductase inhibitor therapy
167. The response to lovastatin treatment in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphism
168. Association between serum lipids and apolipoprotein E phenotype is influenced by diet in a population-based sample of free living children and young adults: The Cardiovascular Risk in Young Finns Study
169. Serum cholesterol, cholesterol precursors, and plant sterols in hypercholesterolemic subjects with different apo E phenotypes during dietary sitostanol ester treatment
170. Dietary sitostanol related to absorption, synthesis and serum level of cholesterol in different apolipoprotein E phenotypes
171. A controlled study on the effect of beta-glucan-rich oat bran on serum lipids in hypercholesterolemic subjects: Relation to apolipoprotein E phenotype
172. The apolipoprotein E gene and the serum low density lipoprotein cholesterol response to dietary fiber
173. Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype
174. Cholesterol absorption and metabolism and LDL kinetics in healthy men with different apoprotein E phenotypes and apo protein B Xbal and LDL receptor PvulI genotypes
175. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E
176. Postprandial plasma lipoprotein changes in relation to apolipoprotein E phenotypes and low density lipoprotein size in men with and without coronary artery disease
177. Lipolytic enzymes and plasma lipoprotein metabolism
178. Structure and polymorphic map of human lipoprotein lipase
179. Assignment of the human lipoprotein lipase (LPL) gene to chromosome band 8p22
180. Two polymorphisms in the human lipoprotein lipase gene
181. RFLP for human lipoprotein lipase gene HindIll
182. 447 → Ter) in a Turkish family
183. Lipoprotein lipase genotypes for a common premature termination codon mutation detected by PCR-mediated site-directed mutagenesis and restriction digestion
184. Genetic variation at the lipoprotein lipase gene associates with coronary arteriosclerosis
185. Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipo proteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden
186. Lipoprotein and hepatic lipase gene variants in coronary atherosclerosis